Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
- Authors:
- Amjad Khan
- Somia Iqtadar
- Sami Ullah Mumtaz
- Michael Heinrich
- Domingo A. Pascual-Figal
- Shona Livingstone
- Sajid Abaidullah
- Reference:
- Frontiers in Pharmacology
- 2022
- 13
- 898062
- DOI:
- 10.3389/fphar.2022.898062